What is Psychemedics?
Founded in 1986 and headquartered in the United States, Psychemedics is a prominent provider of patented hair testing technology for drug detection. The company's core offerings include advanced drug testing processes primarily utilized for pre-employment and random screening purposes. Psychemedics caters to a diverse clientele across various sectors, including corporate entities, law enforcement agencies, financial institutions, and educational organizations. Their commitment to research and development in the drug testing industry positions them as innovators, offering sophisticated alternatives to conventional testing methodologies. The company operates with a business-to-business and business-to-consumer model within the specialized domain of substance abuse detection.
How much funding has Psychemedics raised?
Psychemedics has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Psychemedics
PPP
Public-Private Partnership
What's next for Psychemedics?
The recent major strategic investment of $2M indicates a pivotal moment for Psychemedics, likely signaling a phase of accelerated growth and market expansion. Given the enterprise-level funding context, this capital infusion is expected to bolster research and development initiatives, enhance operational capabilities, and potentially broaden the company's service reach. Psychemedics is poised to further solidify its position as a leader in drug detection technology, leveraging this strategic backing to innovate and meet the evolving demands of its diverse client base.
See full Psychemedics company page
